Ceapro Announces Grant of Stock Options
03 1월 2014 - 9:00PM
Marketwired
Ceapro Announces Grant of Stock Options
EDMONTON, ALBERTA--(Marketwired - Jan 3, 2014) - Ceapro Inc.
(TSX-VENTURE:CZO) today announced the granting of stock options to
its employees, directors, and officers for a total of 930,000 stock
options, each with an exercise price of $0.10. Each grant vests in
three equal instalments, the first of which vests immediately with
the second and third instalments vesting on the first and second
anniversaries of the date of grant. Each option is exercisable,
once vested, for a period of ten years from the date of grant.
Of note, a total of 450,000 of the stock options were granted to
directors and officers. The granting of all options is subject to
TSX Venture approval.
About Ceapro Inc.
Ceapro Inc. is a Canadian growth-stage biotechnology company.
Primary business activities relate to the development and
commercialization of active ingredients for personal care and
cosmetic industries using proprietary technology and natural,
renewable resources. To learn more about Ceapro, visit
www.ceapro.com.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Ceapro Inc.Branko JankovicVice President and
CFO780.917.8376bjankovic@ceapro.comwww.ceapro.com
Ceapro (TSXV:CZO)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Ceapro (TSXV:CZO)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024
